Therapy (HCV)

Ribavirin OK For Dialysis Patients With Hepatitis C, But Close Monitoring Is Needed

Published in Hepatitis Weekly, August 20th, 2001

by Sonia Nichols, senior medical writer - Ribavirin can be used in conjunction with interferon (IFN)-alpha to combat hepatitis C virus (HCV) in dialysis patients, but close patient monitoring for adverse effects is advised, researchers in Sweden suggest.

To study how patients on dialysis respond to IFN/ribavirin dosing regimens normally given to HCV patients not on dialysis, researchers at the Karolinska Institute and Huddinge University Hospital in Stockholm, Sweden, enrolled five hemodialysis patients and one peritoneal dialysis patient, all infected with HCV, in a 28-week trial of the combination therapy.

Overall, four patients were able to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-08-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry